Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

<p>Abstract</p> <p>After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-year survival of 21% achieved with adjuvant chemotherapy. Investigators fro...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Schmitz-Winnenthal H, Lindel K, Seiler C, Hoffmann K, Schmidt J, Märten A, Knaebel HP, Fritz S, Herrmann T, Goldschmidt H, Krempien R, Mansmann U, Debus J, Diehl V, Büchler MW
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2005-04-01
Serie:	BMC Cancer
Accesso online:	http://www.biomedcentral.com/1471-2407/5/37
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

Documenti analoghi